copper gluconate has been researched along with Delayed Graft Function in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadban, SJ; Clayton, PA; Collins, MG; Dansie, KB; Fahim, MA; Hawley, CM; Howard, K; Johnson, DW; McArthur, CJ; McConnochie, RC; Mount, PF; Pascoe, EM; Reidlinger, D; Robison, L; Varghese, J; Vergara, LA; Weinberg, L | 1 |
| Mount, P; Roberts, MA; Wan, S | 1 |
1 review(s) available for copper gluconate and Delayed Graft Function
| Article | Year |
|---|---|
Normal saline versus lower-chloride solutions for kidney transplantation.
Topics: Adult; Delayed Graft Function; Gluconates; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Infusions, Intravenous; Isotonic Solutions; Kidney; Kidney Transplantation; Magnesium Chloride; Potassium Chloride; Ringer's Solution; Sodium Acetate; Sodium Chloride; Solutions | 2016 |
1 trial(s) available for copper gluconate and Delayed Graft Function
| Article | Year |
|---|---|
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% sali
Topics: Administration, Intravenous; Australia; Clinical Trials, Phase III as Topic; Delayed Graft Function; Double-Blind Method; Fluid Therapy; Gluconates; Graft Survival; Humans; Kidney Transplantation; Magnesium Chloride; Multicenter Studies as Topic; Perioperative Care; Postoperative Complications; Potassium Chloride; Pragmatic Clinical Trials as Topic; Quality of Life; Registries; Saline Solution; Sodium Acetate; Sodium Chloride; Tissue Donors; Treatment Outcome | 2020 |